Mytos
- 01/12/2023
- Series A
- $19,000,000
Mytos automates one of the last highly manual processes in biotech - growing human cells.
Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data.
Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL. We're hiring now- visit our website to see open positions
- Industry Biotechnology Research
- Website https://www.mytos.bio/
- LinkedIn https://www.linkedin.com/company/mytosbio/about/
Related People
Ali AfsharCo Founder
I'm a mixture between a scientist and an engineer, having solved challenges both using physics/chemistry, as well as through building hardware and software. I aspire to operate at the interface of science and engineering, where low level science translates into meaningful products.
I see entrepreneurship as a tool to bring together strong teams and affect change